Cargando…

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?

Detalles Bibliográficos
Autor principal:	Abobaker, Anis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325475/ https://www.ncbi.nlm.nih.gov/pubmed/32607779 http://dx.doi.org/10.1007/s00228-020-02942-9

Ejemplares similares

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

The effect of COVID-19 on parathyroid glands
por: Abobaker, Anis, et al.
Publicado: (2021)

Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2020)

COVID‐19 infection as a possible cause of complete heart block: What do we know so far?
por: Abobaker, Anis
Publicado: (2022)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

The Eye: A Possible New Route of Infection in COVID-19
por: Abobaker, Anis, et al.
Publicado: (2020)

Does COVID-19 affect male fertility?
por: Abobaker, Anis, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Postoperative Follow-up After a Total Hip and Knee Joints Replacement
por: Abobaker, Anis, et al.
Publicado: (2020)

Letter to the Editor From Abobaker and Darrat: “Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients”
por: Abobaker, Anis, et al.
Publicado: (2021)

COVID-19 in Libya: Fewer Cases So Far. Any Speculations?
por: Gasibat, Qais, et al.
Publicado: (2020)

Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
por: Dalamaga, Maria, et al.
Publicado: (2020)

V1 and V2 pericordial leads misplacement and its negative impact on ECG interpretation and clinical care
por: Abobaker, Anis, et al.
Publicado: (2021)

Should every Patient with MDS get Iron Chelation – Probably Yes
por: Ghosh, Kanjaksha, et al.
Publicado: (2017)

Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
por: Alavi, Samin, et al.
Publicado: (2014)

Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
por: Vini, Dimitra, et al.
Publicado: (2011)

Adjunctive treatment for leg ulcers
por: Langer, Vijay
Publicado: (2014)

Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation
por: Naoum, Flávio Augusto, et al.
Publicado: (2017)

Can Vitamin D supplementation be used as adjunctive treatment for oligozoospermia or asthenozoospermia accompanied with Vitamin D deficiency?
por: Yan, Wen-Jie, et al.
Publicado: (2015)

Vitamins as adjunctive treatment for coronavirus disease!
por: Kapoor, Indu, et al.
Publicado: (2020)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy
por: Bhardwaj, Ankit, et al.
Publicado: (2021)

The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators
por: Habib, Hosam M., et al.
Publicado: (2021)

Can Coinfection With Influenza Worsen COVID-19 Outcomes?
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

The Two Adjuncts of Sanatorium Treatment
Publicado: (1913)

Can Honey be Used as an Adjunct in Treatment of Post Tonsillectomy Pain?
por: Hasanzadeh Kiabi, Farshad, et al.
Publicado: (2014)

Ozone adjunct treatment in facing multidrug‐resistant bacteria?
por: Chirumbolo, Salvatore, et al.
Publicado: (2023)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
por: Taher, Ali T, et al.
Publicado: (2016)

DCCP and DICP: Construction and Analyses of Databases for Copper- and Iron-Chelating Proteins
por: Wu, Hao, et al.
Publicado: (2005)

Possible role of zinc (Zn) as an adjunctive therapy in gastrointestinal symptoms of COVID-19 infectious disease
por: Abbasinazari, Mohammad
Publicado: (2020)

Iron chelates hitch a ride on PAT1
por: Collins, James F.
Publicado: (2021)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma
por: Jain, Sahil, et al.
Publicado: (2016)

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022)

Therapeutic potential of induced iron depletion using iron chelators in Covid-19
por: Poonkuzhi Naseef, Punnoth, et al.
Publicado: (2022)

Inhaled iloprost can improve oxygenation and shunt fraction in severe COVID-19
por: Serbanescu-Kele Apor de Zalán, Christiaan M.C., et al.
Publicado: (2022)

Iron and Zinc Treatment in Iron Deficiency
por: Joob, Beuy, et al.
Publicado: (2016)

Hysteresis Loop Can be an Adjunct Monitoring for Neuromuscular Blockade while on Controlled Ventilation During Low- and Minimal-Flow Anaesthesia
por: Karim, Habib Md Reazaul
Publicado: (2020)

Correction to: Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2021)

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
por: Tamez, Hector E., et al.
Publicado: (2015)

Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”
por: Vuorio, Alpo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0tgsbe6344p1ttp75b0lmovgv